References

Abdi-Ali, A., E.A. Worobec, A. Deezagi and F. Malekzadeh, 2004. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Can. J. Microbiol., 50: 375-381.
PubMed  |  

Asaduzzaman, S.M. and K. Sonomoto, 2009. Lantibiotics: Diverse activities and unique modes of action. J. Biosci. Bioeng., 107: 475-487.
CrossRef  |  

Draper, L.A., K. Grainger, L.H. Deegan, P.D. Cotter, C. Hill and R.P. Ross, 2009. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol., 71: 1043-1054.
PubMed  |  

Dubin, A., P. Mak, G. Dubin, M. Rzychon and J. Stec-Niemczyk et al., 2005. New generation of peptide antibiotics. Acta Biochim. Pol., 52: 633-638.
PubMed  |  

Duffes, F., P. Jenoe and P. Boyaval, 2000. Use of two-dimensional electrophoresis to study differential protein expression in divercin V41-resistant and wild-type strains of Listeria monocytogenes. Applied Environ. Microbiol., 66: 4318-4324.
PubMed  |  

Gravesen, A., A. A. Jydegaard, S. J. Mendes, T. B. Hansen and S. Knochel, 2002. Frequency of bacteriocin resistance development and associated fitness costs in Listeria monocytogenes. Applied Environ. Microbiol., 68: 756-764.
CrossRef  |  PubMed  |  

Guinane, C.M., P.D. Cotter, C. Hill and R.P. Ross, 2006. Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147. FEMS Microbiol. Lett., 260: 77-83.
PubMed  |  

Hammami, R., A. Zouhir, L.C. Le, H.J. Ben and I. Fliss, 2010. BACTIBASE second release: A database and tool platform for bacteriocin characterization. BMC Microbiol., 10: 22-22.
Direct Link  |  

Jasniewski, J., C. Cailliez-Grimal, M. Younsi, J. Milliere and A. Revol-Junelles, 2008. Functional differences in Leuconostoc sensitive and resistant strains to mesenterocin 52A, a class IIa bacteriocin. FEMS Microbiol. Lett., 289: 193-201.
PubMed  |  

Kirkup, B.C., 2006. Bacteriocins as oral and gastrointestinal antibiotics: Theoretical considerations, applied research and practical applications. Curr. Med. Chem., 13: 3335-3350.
PubMed  |  

Klaenhammer, T.R., 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev., 12: 39-85.
CrossRef  |  PubMed  |  Direct Link  |  

Kumarasamy, K.K., M.A. Toleman, T.R. Walsh, J. Bagaria and F. Butt et al., 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: A molecular, biological and epidemiological study. Lancet Infect. Dis., 10: 597-602.
CrossRef  |  Direct Link  |  

Landy, M., G.H. Warren, S.B. Rosenman and L.G. Colio, 1948. Bacillomycin: An antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. Exp. Biol. Med., 67: 539-541.
PubMed  |  

Limonet, M., A.M. Revol-Junelles and J.B. Milliere, 2002. Variations in the membrane fatty acid composition of resistant or susceptible Leuconostoc or Weissella strains in the presence or absence of Mesenterocin 52A and Mesenterocin 52B produced by Leuconostoc mesenteroides subsp. mesenteroides FR52. Applied Environ. Microbiol., 68: 2910-2916.
CrossRef  |  PubMed  |  

Limonet, M., A.M. Revol-Junelles and J.B. Milliere, 2002. Variations in the membrane fatty acid composition of resistant or susceptible Leuconostoc or Weissella strains in the presence or absence of Mesenterocin 52A and Mesenterocin 52B produced by Leuconostoc mesenteroides subsp. mesenteroides FR52. Applied Environ. Microbiol., 68: 2910-2916.
CrossRef  |  PubMed  |  

Mota-Meira, M., G. Lapointe, C. Lacroix and M.C. Lavoie, 2000. MICs of mutacin B-Ny266, nisin A, vancomycin and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother., 44: 24-29.
PubMed  |  

Naghmouchi, K., E. Kheadr, C. Lacroix and I. Fliss, 2007. Class I/class IIa bacteriocin cross-resistance phenomenon in Listeria monocytogenes. Food Microbiol., 24: 718-727.
CrossRef  |  PubMed  |  Direct Link  |  

Opsata, M., I.F. Nes and H. Holo, 2010. Class IIa bacteriocin resistance in Enterococcus faecalis V583: The mannose PTS operon mediates global transcriptional responses. BMC Microbiol., 10: 224-224.
Direct Link  |  

Parisien, A., B. Allain, J. Zhang, R. Mandeville and C.Q. Lan, 2008. Novel alternatives to antibiotics: Bacteriophages, bacterial cell wall hydrolases and antimicrobial peptides. J. Applied Microbiol., 104: 1-13.
CrossRef  |  PubMed  |  Direct Link  |  

Sakayori, Y., M. Muramatsu, S. Hanada, Y. Kamagata, S. Kawamoto and J. Shima, 2003. Characterization of Enterococcus faecium mutants resistant to mundticin KS, a class IIa bacteriocin. Microbiology, 149: 2901-2908.
CrossRef  |  

Vadyvaloo, V., J.L. Snoep, J.W. Hastings and M. Rautenbach, 2004. Physiological implications of class IIa bacteriocin resistance in Listeria monocytogenes strains. Microbiology, 150: 335-340.
PubMed  |  

Vadyvaloo, V., S. Arous, A. Gravesen, Y. Hechard, R. Chauhan-Haubrock, J.W. Hastings and M. Rautenbach, 2004. Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains. Microbiology, 150: 3025-3033.
PubMed  |  

Watanabe, M., M. Inoue and S. Mitsuhashi, 1989. In vitro activity of amifloxacin against outer membrane mutants of the family Enterobacteriaceae and frequency of spontaneous resistance. Antimicrob. Agents Chemother., 33: 1837-1840.
PubMed  |  

Xie, J., R. Zhang, C. Shang and Y. Guo, 2009. Isolation and characterization of a bacteriocin produced by an isolated Bacillus subtilis LFB112 that exhibits antimicrobial activity against domestic animal pathogens. Afr. J. Biotechnol., 8: 5611-5619.
Direct Link  |